Confirmation of preeclampsia-like syndrome induced by severe COVID-19 : An Observational Study
Serrano, Berta (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Bonacina, Erika (Hospital Universitari Vall d'Hebron)
Garcia-Ruiz, Itziar (Hospital Universitari Vall d'Hebron)
Mendoza, Manel (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Garcia-Manau, Pablo (Hospital Universitari Vall d'Hebron)
Garcia-Aguilar, Paula (Hospital Universitari Vall d'Hebron)
Gil, Judit (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Armengol-Alsina, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Fernández-Hidalgo, Nuria (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Sulleiro Igual, Elena (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
Castillo-Ribelles, Laura (Hospital Universitari Vall d'Hebron)
Maiz, Nerea (Hospital Universitari Vall d'Hebron)
Carreras Moratonas, Elena (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Suy, Anna (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)

Date:	2022
Abstract:	Since the outbreak of the COVID-19 pandemic, some studies have reported an increased preeclampsia (PE) incidence in pregnant women with SARS-CoV-2 infection. Several explanations for this association have been proposed, including a preeclampsia-like syndrome induced by severe COVID-19. This syndrome was described in a small case series and has not been confirmed in larger studies and its impact in perinatal outcomes has not been studied. The aim of this study was to confirm the preeclampsia-like syndrome due to COVID-19 and to investigate its implications in pregnancy outcomes and prognosis. This was a prospective, observational study conducted in a tertiary referral hospital. Inclusion criteria were pregnant women admitted to the Intensive Care Unit for severe pneumonia due to COVID-19. They were classified in three groups based on clinical and laboratory findings: PE, PE-like syndrome, and women without PE features. The three cohorts were analyzed and compared at three different times: before, during and after severe pneumonia. The main outcomes were incidence of adverse perinatal outcomes and signs and symptoms of PE, such as hypertension, proteinuria, thrombocytopenia, elevated liver enzymes and increased angiogenic factors (soluble fms-like tyrosine kinase-1 to placental growth factor ratio [sFlt-1/PlGF]). A total of 106 women were admitted to Intensive Care Unit due to severe pneumonia and 68 were included in the study. Of those, 53 (50. 0%) did not meet the diagnostic criteria for PE and remained pregnant after pneumonia (non-PE), seven (6. 6%) met the diagnostic criteria for PE, had abnormal (>38) sFlt-1/PlGF (PE) and delivered during severe pneumonia, and eight (7. 5%) met the diagnostic criteria for PE, had normal (≤38) sFlt-1/PlGF (PE-like) and did not deliver during pneumonia. Despite not having delivered, most PE-related features improved after severe pneumonia in women with PE-like syndrome. Women with PE had significantly poorer outcomes than women with PE-like syndrome or without PE. More than 50% of women with severe COVID-19 and diagnostic criteria for PE may not be PE but a PE-like syndrome, which may affect up to 7. 5% of women with severe COVID-19. PE-like syndrome might have similar perinatal outcomes to those of normotensive women with severe pneumonia due to COVID-19. For these reasons, PE-like syndrome should be excluded by using sFlt-1/PlGF in future research and before making clinical decisions.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Angiogenic factors ; Sflt-1/plgf ; Pre-eclampsia ; Pre-eclampsia-like syndrome ; SARS-CoV-2 ; COVID-19 ; Pregnancy
Published in:	American journal of obstetrics & gynecology, maternal-fetal medicine, october 2022, ISSN 2589-9333

DOI: 10.1016/j.ajogmf.2022.100760
PMID: 36195282

10 p, 364.8 KB

The record appears in these collections:
Articles > Research articles
Articles > Published articles